BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1679760)

  • 1. Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas.
    Saranath D; Bhoite LT; Mehta AR; Sanghavi V; Deo MG
    J Cancer Res Clin Oncol; 1991; 117(5):484-8. PubMed ID: 1679760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-ras-1 restriction fragment length polymorphism in normal individuals and oral cancer patients in India.
    Bhoite LT; Saranath D; Nair R; Deo MG; Sanghavi V; Mehta A
    J Oral Pathol Med; 1993 Aug; 22(7):298-302. PubMed ID: 7901404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Harvey ras heterozygosity in oral squamous carcinoma.
    Howell RE; Wong FS; Fenwick RG
    J Oral Pathol Med; 1989 Feb; 18(2):79-83. PubMed ID: 2568483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure.
    Yuan B; Heniford BW; Ackermann DM; Hawkins BL; Hendler FJ
    Cancer Res; 1994 Oct; 54(20):5310-7. PubMed ID: 7923158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosage and allelic restriction fragment studies and PCR analysis of the H-ras locus in giant cell tumor of bone.
    Dahir GA; Vnencak-Jones CL; Schwartz HS; Butler MG
    Cancer Genet Cytogenet; 1994 Jun; 74(2):95-8. PubMed ID: 7912645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping loss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis.
    Bianchi AB; Navone NM; Aldaz CM; Conti CJ
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7590-4. PubMed ID: 1909026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.
    Vachtenheim J; Horáková I; Novotná H
    Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of two TaqI polymorphisms in the VTR region of the human HRAS1 oncogene.
    Pierotti MA; Radice P; Biunno I; Borrello MG; Cattadori MR; Della Porta G
    Cytogenet Cell Genet; 1986; 43(3-4):174-80. PubMed ID: 2879707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrequent loss of heterozygosity at adenomatous polyposis coli gene locus in Indian oral cancers.
    Tandle A; Sanghavi V; Saranath D
    Cancer Lett; 2000 Sep; 157(2):155-60. PubMed ID: 10936675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
    Anderson JA; Irish JC; McLachlin CM; Ngan BY
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):755-60. PubMed ID: 7912510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin of rare Ha-ras alleles: relationship of VTR length to a 5' polymorphic Xho I site.
    Baxter GD; Hayward NK; Collins RJ; Lavin MF
    Genet Res; 1989 Oct; 54(2):149-53. PubMed ID: 2558964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.
    Ryberg D; Tefre T; Skaug V; Stangeland L; Ovrebø S; Naalsund A; Børresen AL; Haugen A
    Environ Health Perspect; 1992 Nov; 98():187-9. PubMed ID: 1362538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.
    Wong WW; Cahill JM; Rosen MD; Kennedy CA; Bonaccio ET; Morris MJ; Wilson JG; Klickstein LB; Fearon DT
    J Exp Med; 1989 Mar; 169(3):847-63. PubMed ID: 2564414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method to analyze allele-specific methylation.
    Bedford MT; van Helden PD
    Biotechniques; 1990 Dec; 9(6):744-8. PubMed ID: 1980196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular lesions in human oral cancer: the Indian scene.
    Saranath D; Bhoite LT; Deo MG
    Eur J Cancer B Oral Oncol; 1993 Apr; 29B(2):107-12. PubMed ID: 7910088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma.
    Ogata N; Kamimura T; Asakura H
    Hepatology; 1991 Jan; 13(1):31-7. PubMed ID: 1846346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals].
    Shan X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology.
    Huang MF; Chang YC; Liao PS; Huang TH; Tsay CH; Chou MY
    Oral Oncol; 1999 May; 35(3):296-301. PubMed ID: 10621851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human restriction fragment length polymorphisms and cancer risk assessment.
    Krontiris TG; DiMartino NA; Colb M; Mitcheson HD; Parkinson DR
    J Cell Biochem; 1986; 30(4):319-29. PubMed ID: 3011817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a rare point mutation at codon 59 and relatively high incidence of H-ras mutation in Indian oral cancer.
    Munirajan AK; Mohanprasad BK; Shanmugam G; Tsuchida N
    Int J Oncol; 1998 Nov; 13(5):971-4. PubMed ID: 9772288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.